Section Arrow
SNN.NYSE
- Smith & Nephew plc
Quotes are at least 15-min delayed:2025/06/29 02:03 EDT
Last
 30.22
+0.01 (+0.03%)
Day High 
30.37 
Prev. Close
30.21 
1-M High
30.4 
Volume 
882.88K 
Bid
29.78
Ask
30.52
Day Low
30.12 
Open
30.22 
1-M Low
28.4 
Market Cap 
13.22B 
Currency USD 
P/E 32.14 
%Yield 2.48 
10-SMA 29.4 
20-SMA 29.5 
50-SMA 28.48 
52-W High 31.72 
52-W Low 23.69 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.94/2.57
Enterprise Value
16.48B
Balance Sheet
Book Value Per Share
12.03
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
5.81B
Operating Revenue Per Share
12.23
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/29 02:03 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.